- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07922304
Aroma Inhalation and Exam Stress: Role of Emotional Intelligence and Stress Biomarkers
Effect of Aroma Inhalations (Thyme and Juniper) on Exam Stress and Apelin and Cerebral (BDNF) Stress Response (GRP78) According to Emotional Intelligence Levels and Stress Management Skills
This study is an interventional investigation aiming to evaluate the physiological effects of thyme (Thymus vulgaris) and juniper (Juniperus communis) essential oil aroma inhalation on examination stress in medical students. The research assesses participants' emotional intelligence and exam anxiety levels, and analyzes changes in salivary apelin, BDNF, and GRP78 levels using the ELISA method before and after the aromatherapy intervention.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Purpose: This study aims to investigate the effects of aroma inhalations (thyme and juniper) on exam stress, adipokines (apelin), neurotrophic factors (BDNF), and endoplasmic reticulum stress responses (GRP78) based on emotional intelligence and exam anxiety levels in medical students. Methods: The study is a three-arm, randomized, controlled interventional investigation conducted on healthy volunteer medical students. Saliva samples are collected before inhalation and immediately after the 15-minute intervention. The ELISA technique is utilized to determine salivary apelin, BDNF, and GRP78 levels.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Altindag
-
Ankara, Altindag, Turkey (Türkiye), 06050
- Ankara Medipol University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Being willing to participate in the research, being a medical student, not having a cardiovascular disease, not having any allergies to odors, not being pregnant, not having any respiratory system diseases (such as asthma, COPD, etc.), not having any condition that prevents smelling, not using any medication that affects heart rate and blood pressure, and not having any psychiatric illness.
Exclusion Criteria:
The communication barrier, incomplete filling of forms, menstruation in girls, allergy to the scents of thyme and juniper oil, and the occurrence of any side effects during the application.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Juniper Aromatherapy Group
Participants inhale juniper essential oil for 40 minutes during the exam. Physiological and hormonal measurements are taken before and after inhalation. |
Participants inhale juniper essential oil (2 drops) via a diffuser or inhaler for approximately 40 minutes during the exam session. This inhalation is intended to assess effects on anxiety-related physiological and hormonal parameters. |
|
Experimental: Thyme Aromatherapy Group
Participants inhale thyme essential oil for 40 minutes during the exam. Physiological and hormonal measurements are taken before and after inhalation. |
Participants inhale thyme essential oil (2 drops) via a diffuser or inhaler for approximately 40 minutes during the exam session. This inhalation is intended to assess effects on anxiety-related physiological and hormonal parameters. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Salivary Apelin Levels
Time Frame: Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Salivary apelin levels will be measured to evaluate the metabolic and neuroendocrine response to aroma inhalation. |
Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
|
Change in Salivary BDNF Levels
Time Frame: Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Salivary BDNF levels will be measured as a neurotrophic and physiological stress indicator. |
Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
|
Change in Salivary GRP78 Levels
Time Frame: Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Salivary GRP78 levels will be measured to monitor cellular endoplasmic reticulum stress responses. |
Immediately before inhalation and immediately after the 15-minute inhalation intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AROMA-MED-2025-02
- E-81477236-604.01.01-3006 (Other Identifier: Ethics Committee Approval Number, Ankara Medipol University Faculty of Medicine, Turkey)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The individual participant data (IPD) will not be shared due to ethical considerations and institutional restrictions.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.